Poehling Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-300	Closed	-$12K	–	160
2018 Q2	$12K	Hold	300	–	–	0.01%	218
2018 Q1	$22K	Hold	300	–	–	0.02%	187
2017 Q4	$20K	Buy	+300	New	+$20K	0.02%	184